cefuroxime has been researched along with Cancer of Larynx in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scotton, W | 1 |
| Cobb, R | 1 |
| Pang, L | 1 |
| Nixon, I | 1 |
| Joshi, A | 1 |
| Jeannon, JP | 1 |
| Oakley, R | 1 |
| French, G | 1 |
| Hemsley, C | 1 |
| Simo, R | 1 |
1 other study available for cefuroxime and Cancer of Larynx
| Article | Year |
|---|---|
Post-operative wound infection in salvage laryngectomy: does antibiotic prophylaxis have an impact?
Topics: Administration, Intravenous; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Cohort Studi | 2012 |